Our client is a global healthcare leader that helps people live more fully at all stages of life. Their portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Their 103,000 colleagues serve people in more than 160 countries.
Our client is a new division of a $20 billion conglomerate that was established in 1953. They have developed their business portfolio into four core sectors, Food and Food Service, Bio and Pharma, Entertainment and Media, and Retail and Logistics. Based in the Trenton, New Jersey area, the new division seeks a Director of R&D to develop new Asian products sold B2B in the US.
Our client is known around the world as the founder of the non-dairy segment of the frozen food industry and the leading supporter and solutions provider to the Food Service, In-Store Bakery and Retail marketplaces. They are one of the world’s premier family-owned food companies with more than $3B in sales. They currently have a new opportunity for a Senior Scientist, Innovation at their location in the Northeast.
Our client is a multifaceted company with over a quarter of a century history and rich tradition in the food ingredients industry. They are a multi-dimensional manufacturing enterprise dealing in proprietary, value-added food blends and a widely diverse range of ingredients. They are currently seeking a VP Technical Services for their R&D facility in the Midwest.
Forget free-range, antibiotic-free, and grass-fed—tomorrow’s burger will be lab-cultured. Scientists are creating a new slaughterhouse-free food group called clean meat: edible animal protein grown in a vat. Stem cells are extracted from animals, brewed in a bioreactor, fortified with nutrients like amino acids and glucose, and structured around collagen “scaffolds.” It’s not just about cultivating the ideal boneless chicken wing: These miracle meats could reduce the planet-depleting land and water use of traditional animal agriculture by more than 80 percent. “From an investment standpoint, this is potentially a trillion-dollar market opportunity,” says New Crop Capital partner Christopher Kerr, leading VCs to grab a stake in their labstock of choice.